Efficacy and safety of negative allosteric modulators of 5-hydroxytryptamine 2A receptors in the treatment of Alzheimer’s disease psychosis: A systematic review and meta-analysis
Advances in Clinical and Experimental Medicine · 2023
DOI: 10.17219/acem/161159 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Advances in Clinical and Experimental Medicine, 2023. Verfasst von Yuxiao Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, Shandong University of Traditional Chinese Medicine Affiliated Hospital, Jinan, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases, Psychotic Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rehabilitation, Shandong University of Traditional Chinese Medicine Affiliated Hospital, Jinan, China.
- Department of Neurology, Liaocheng Veterans Hospital, China.
- Department of Movement Sciences, Faculty of Medicine, Katholieke Universiteit Leuven, Belgium.
Zitieren
APA
Chen, Y., Sun, J., Yang, Z., & Bi, H. (2023). Efficacy and safety of negative allosteric modulators of 5-hydroxytryptamine 2A receptors in the treatment of Alzheimer’s disease psychosis: A systematic review and meta-analysis. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/161159
Vancouver
Chen Y, Sun J, Yang Z, Bi H. Efficacy and safety of negative allosteric modulators of 5-hydroxytryptamine 2A receptors in the treatment of Alzheimer’s disease psychosis: A systematic review and meta-analysis. Advances in Clinical and Experimental Medicine. 2023. doi:10.17219/acem/161159
BibTeX
@article{Chen2023,
author = {Chen, Yuxiao and Sun, Jie and Yang, Zhen and Bi, Hongyan},
title = {Efficacy and safety of negative allosteric modulators of 5-hydroxytryptamine 2A receptors in the treatment of Alzheimer’s disease psychosis: A systematic review and meta-analysis},
journal = {Advances in Clinical and Experimental Medicine},
year = {2023},
doi = {10.17219/acem/161159}
}
EUVIMED